| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 26.392 | 51.056 | 52.780 | 49.389 | 48.917 | 51.611 |
| Total Income - EUR | - | - | - | 0 | 26.393 | 51.062 | 52.794 | 49.393 | 48.917 | 54.473 |
| Total Expenses - EUR | - | - | - | 1.119 | 10.218 | 21.602 | 27.894 | 27.584 | 33.712 | 35.269 |
| Gross Profit/Loss - EUR | - | - | - | -1.119 | 16.175 | 29.459 | 24.900 | 21.809 | 15.205 | 19.204 |
| Net Profit/Loss - EUR | - | - | - | -1.119 | 15.384 | 28.959 | 24.435 | 21.325 | 14.776 | 17.603 |
| Employees | - | - | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Onco Med Silvania S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 17.580 | 13.015 | 8.867 | 4.665 | 1.468 |
| Current Assets | - | - | - | 213 | 18.489 | 37.599 | 60.849 | 14.533 | 18.556 | 19.567 |
| Inventories | - | - | - | 0 | -13 | 8 | 0 | 20 | 0 | 170 |
| Receivables | - | - | - | 0 | 99 | 226 | 178 | 4.729 | 6.534 | 4.437 |
| Cash | - | - | - | 213 | 18.403 | 37.365 | 60.672 | 9.784 | 12.022 | 14.960 |
| Shareholders Funds | - | - | - | -1.076 | 14.329 | 43.016 | 66.497 | 21.517 | 22.077 | 19.453 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.289 | 4.161 | 12.164 | 7.367 | 1.884 | 1.144 | 1.582 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Onco Med Silvania S.r.l.